Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

CymaBay stops clinical development of seladelpar

Nov. 26, 2019

Shanghai Institute of Materia Medica patents farnesoid X receptor agonists

Nov. 26, 2019

NASH progression tied to redox state

Nov. 25, 2019

ALG-055009: a THR-beta agonist for treating NASH

Nov. 22, 2019

Positive preclinical data reported for leronlimab in humanized mouse model of NAFLD

Nov. 22, 2019

Pfizer presents early clinical data for PF-06865571 and PF-05221304

Nov. 22, 2019

ZGN-1345 demonstrates promise in preclinical models of NASH and HCC

Nov. 21, 2019

New ASK1/TAK1 dual kinase inhibitor for treating NASH presented

Nov. 20, 2019

Interim analysis of phase II data for licogliflozin in NASH

Nov. 19, 2019

Inhibition of fatty acid synthase with FT-4101 reduces hepatic de novo lipogenesis in healthy adults

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...